Yoga Guru's Blitz In India Fails To Dent Unilever's Sales Gain
Hindustan Unilever Ltd's revenue climbed to a record in the fourth quarter as India's largest consumer-goods company shrugged off competition including from yoga guru Baba Ramdev's Patanjali Ayurved Ltd. Revenue at the Indian unit of Unilever rose 2.6 percent to Rs 9,000 crore ($1.3 billion) in the three months through March, the Mumbai-based company said in a statement Monday. That exceeded the Rs 8,900 crore average estimate of 21 analysts compiled by Bloomberg. Net income increased to Rs 1,350 crore, beating analyst estimates. Revenue from company's home care segment, which includes brands such as Surf Excel and Vim, rose 3.26 per cent to Rs 3,102 crore.
Hindustan Unilever (HUL), which is benefiting from a pick up in consumption, and as deliveries recover from India's biggest tax overhaul, has sustained its sales growth by adding natural and ayurveda-based products. That's also helping it counter competition across its segments from detergents to skin creams from local companies, which are building their brands using yoga and spiritual leaders.
"The market for naturals and ayurveda products is big," chief financial officer Srinivas Phatak said on a conference call on Monday.
"Hindustan Unilever has a three-pronged strategy focusing on core brands including Hamam and Ponds, special brands such as Indulekha hair oil and Lever Ayush as master brands."
Ramdev, who has said he's an "unpaid ambassador" at Patanjali, said in January that the company will overtake Unilever in India next year. Over the past few years, Patanjali has expanded its portfolio of products to include almost all the segments Hindustan Unilever operates in the country.
(This story has not been edited by NDTV staff and is auto-generated from a syndicated feed.)
-
Getting To Work Costs Women More | The Reason Why
It is not just about women paying more than men. It is about women paying much more in cities than in villages.
-
AI Bias In Investing Cannot Be Eliminated, But It Can Be Governed
Framing is a particularly important example as identical financial information presented in terms of gains rather than losses can lead an LLM to reach a different assessment.
-
Joining The Dots | Dark Skies, Steady Diya: Why Hope Holds This Diwali
With war, a weak rupee and foreign outflows weighing on sentiment, policymakers at the NDTV World Summit and market veterans at NDTV Profit Ignite: Diwali Edition offered the same advice: stay invested and filter out the noise.
-
The Curious Case of Equitas Small Finance Bank And A CEO Who Quit For Stock
PN Vasudevan believes persistent investor concerns over a perceived conflict of interest had become a governance overhang on Equitas Small Finance Bank's stock, even as the lender improved profitability and asset quality.
-
Talking Points This Week: AI Cash Burn, A Tiger Comeback And An India That Still Finds Its Own Path
India is not immune to higher oil or tighter global liquidity, yet its earnings base is broader, its domestic policy levers are still available.
-
Foreign Investors Own Half Of HDFC Bank and ICICI Bank. An LTCG Cut Could Matter Most Here
Foreign portfolio investors have US$115 billion parked in HDFC Bank, ICICI Bank. If the government cuts long-term capital gains tax, Jefferies says returning foreign money could land here first.
-
'Never Seen This Level Of Negativity': Sandeep Tandon Says The Next Rally May Be Closer Than You Think
Veteran investor Sandeep Tandon says foreign selling is easing, large-caps are due a comeback and mid-caps are crowded, while he turns positive on gold, power and pharma this Diwali.
-
Indians Stay With Family, Not In Hotels | The Reason Why
India still lacks enough clean, reliable and affordable hotels for budget-conscious travellers.
-
The Economic Imperative: Analysing The Material Driving Force Behind India-Canada Strategic Reset
This economic complementarity is further reinforced by deep institutional investment ties and talent mobility, which form the bedrock of the bilateral framework.
-
Medicine Pricing: Where Must Profit Stop?
India must confront excessive margins, hidden incentives and regulatory gaps that threaten the integrity of medicine.